The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders
Open accessAbstract
OBJECTIVE: Type 2 diabetes mellitus (T2DM) is generally regarded as an irreversible chronic condition. Because a very low-calorie diet (VLCD) can bring about acute return to normal glucose control in some people with T2DM, this study tested the potential durability of this normalization. The underlying mechanisms were defined. RESEARCH DESIGN AND METHODS: People with a T2DM duration of 0.5-23 years (n = 30) followed a VLCD for 8 weeks. All oral agents or insulins were stopped at baseline. Following a stepped return to isocaloric diet, a structured, individualized program of weight maintenance was provided. Glucose control, insulin sensitivity, insulin secretion, and hepatic and pancreas fat content were quantified at baseline, after return to isocaloric diet, and after 6 months to permit the primary comparison of change between post-weight loss and 6 months in responders. Responders were defined as achieving fasting blood glucose <7 mmol/L after return to isocaloric diet. RESULTS: Weight fell (98.0 ± 2.6 to 83.8 ± 2.4 kg) and remained stable over 6 months (84.7 ± 2.5 kg). Twelve of 30 participants achieved fasting plasma glucose <7 mmol/L after return to isocaloric diet (responders), and 13 of 30 after 6 months. Responders had a shorter duration of diabetes and a higher initial fasting plasma insulin level. HbA1c fell from 7.1 ± 0.3 to 5.8 ± 0.2% (55 ± 4 to 40 ± 2 mmol/mol) in responders (P < 0.001) and from 8.4 ± 0.3 to 8.0 ± 0.5% (68 ± 3 to 64 ± 5 mmol/mol) in nonresponders, remaining constant at 6 months (5.9 ± 0.2 and 7.8 ± 0.3% [41 ± 2 and 62 ± 3 mmol/mol], respectively). The responders were characterized by return of first-phase insulin response. CONCLUSIONS: A robust and sustainable weight loss program achieved continuing remission of diabetes for at least 6 months in the 40% who responded to a VLCD by achieving fasting plasma glucose of <7 mmol/L. T2DM is a potentially reversible condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Long-term weight loss maintenance
Wing, R. R., & Phelan, S. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.1.222s · Cited by 1,941 · cited 1×
“However, restoration of normal glucose control is possible following weight loss in some individuals with T2DM [5-8].”
BackgroundU.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Michie, S., Ashford, S., Sniehotta, F. F., Dombrowski, S. U., Bishop, A., & French, D. P. (2011) · Psychology & Health · doi:10.1080/08870446.2010.540664 · Cited by 1,756
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., Castagneto, M., Bornstein, S., & Rubino, F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00075-6 · Cited by 1,220
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164
Self-citationHow do we define cure of diabetes?
Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., et al. (2009) · Diabetes Care · doi:10.2337/dc09-9036 · Cited by 1,003
Lee, Y., Hirose, H., Ohneda, M., Johnson, J. H., McGarry, J., & Unger, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10878 · Cited by 832
Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812
Association of an intensive lifestyle intervention with remission of type 2 diabetes
Gregg, E. W., Chen, H., Wagenknecht, L. E., Clark, J. M., Delahanty, L. M., Bantle, J., Pownall, H. J., Johnson, K. C., Safford, M. M., Kitabchi, A. E., et al. (2012) · JAMA · doi:10.1001/jama.2012.67929 · Cited by 752
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes
Hayward, R. A., Reaven, P. D., Wiitala, W. L., Bahn, G. D., Reda, D. J., Ge, L., McCarren, M., Duckworth, W. C., & Emanuele, N. V. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414266 · Cited by 668 · cited 2×
“increasing requirement for hypoglycemic agents over years (2,28,29).”
Knowler, W. C., Bennett, P. H., Hamman, R. F., & Miller, M. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112648 · Cited by 601
Dall, T. M., Yang, W., Gillespie, K., Mocarski, M., Byrne, E. N., Cintina, I., Beronja, K., Semilla, A. P., Iacobucci, W., & Hogan, P. F. (2019) · Diabetes Care · doi:10.2337/dc18-1226 · Cited by 459
NAFLD in Asia—as common and important as in the West
Farrell, G. C., Wong, V. W., & Chitturi, S. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.34 · Cited by 437
Pancreatic Fat Content and β-Cell Function in Men With and Without Type 2 Diabetes
Tushuizen, M. E., Bunck, M. C. M., Pouwels, P. J. W., Bontemps, S., van Waesberghe, J. H. T., Schindhelm, R. K., Mari, A., Heine, R. J., & Diamant, M. (2007) · Diabetes Care · doi:10.2337/dc07-0326 · Cited by 402
Dall, T. M., Yang, W., Halder, P., Pang, B., Massoudi, M., Wintfeld, N., Semilla, A. P., Franz, J., & Hogan, P. F. (2014) · Diabetes Care · doi:10.2337/dc14-1036 · Cited by 382
Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes
Tang, C., Ahmed, K., Gille, A., Lu, S. Y., Gröne, H., Tunaru, S., & Offermanns, S. (2015) · Nature Medicine · doi:10.1038/nm.3779 · Cited by 340
Jackness, C., Karmally, W., Febres, G., Conwell, I. M., Ahmed, L., Bessler, M., McMahon, D. J., & Körner, J. (2013) · Diabetes · doi:10.2337/db12-1762 · Cited by 272
Delahanty, L. M., Grant, R. W., Wittenberg, E., Bosch, J. L., Wexler, D. J., Cagliero, E., & Meigs, J. B. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02028.x · Cited by 248
HENRY, R. R., SCHEAFFER, L., & OLEFSKY, J. M. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-5-917 · Cited by 245
Pancreatic Ectopic Fat Is Characterized by Adipocyte Infiltration and Altered Lipid Composition
Pinnick, K. E., Collins, S., Londos, C., Gauguier, D., Clark, A., & Fielding, B. A. (2008) · Obesity · doi:10.1038/oby.2007.110 · Cited by 220
Normal weight individuals who develop Type 2 diabetes: the personal fat threshold
Taylor, R., & Holman, R. R. (2014) · Clinical Science · doi:10.1042/cs20140553 · Cited by 201
Franco, M., Bilal, U., Ordúñez, P., Rodríguez, M. B., Giraldoni, A. F. M., Caballero, B. H., Kennelly, J. F., & Cooper, R. (2013) · BMJ · doi:10.1136/bmj.f1515 · Cited by 189
Bjorkegren, J., Packard, C. J., Hamsten, A., Bedford, D., Caslake, M., Foster, L., Shepherd, J., Stewart, P., & Karpe, F. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37637-9 · Cited by 187
Self-citationSteven (2016) · doi:10.2337/dc15-0750 · Cited by 171
Steven, S., & Taylor, R. (2015) · Diabetic Medicine · doi:10.1111/dme.12722 · Cited by 124
Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents
Lee, Y., Lingvay, I., Szczepaniak, L. S., Ravazzola, M., Orci, L., & Unger, R. H. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.245 · Cited by 121
Rapid improvement in diabetes after gastric bypass surgery
Lingvay, I., Guth, E., Islam, A., & Livingston, E. (2013) · Diabetes Care · doi:10.2337/dc12-2316 · Cited by 116
Lalloyer, F., Vandewalle, B., Percevault, F., Torpier, G., Kerr-Conte, J. A., Oosterveer, M. H., Paumelle, R., Fruchart, J., Kuipers, F., Pattou, F. N., et al. (2006) · Diabetes · doi:10.2337/db06-0016 · Cited by 115
Effect of Acute Hyperglycemia on Insulin Secretion in Humans
Toschi, E., Camastra, S., Sironi, A. M., Masoni, A., Gastaldelli, A., Mari, A., Ferrannini, E., & Natali, A. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s130 · Cited by 82
Population response to information on reversibility of Type 2 diabetes
Steven, S., Lim, E. L., & Taylor, R. (2013) · Diabetic Medicine · doi:10.1111/dme.12116 · Cited by 70
Development of a novel method to determine very low density lipoprotein kinetics
Al-Shayji, I. A. R., Gill, J. M. R., Cooney, J., Siddiqui, S., & CASLAKE, M. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.d600044-jlr200 · Cited by 17
Pancreatic triacylglycerol distribution in type 2 diabetes
Hollingsworth, K. G., Al-Mrabeh, A. H., Steven, S., & Taylor, R. (2015) · Diabetologia · doi:10.1007/s00125-015-3718-1 · Cited by 14
Type 2 diabetes: remission in just a week
Yki‐Järvinen, H. (2011) · Diabetologia · doi:10.1007/s00125-011-2266-6 · Cited by 14
AssociationofanIntensiveLifestyleIntervention With Remission of Type 2 Diabetes
Gregg, E. W., Chen, H., Wagenknecht, L. E., Clark, J. M., Delahanty, L. M., Bantle, J. P., Pownall, H. J., Johnson, K., Safford, M. M., Kitabchi, A. E., et al. (2016) · Cited by 1
Flagged first, then by citations
Research works printed but not linked: 1
- Himsworth, 1949, Diet in the aetiology of human diabetes, Proc R Soc Med, 42, 323
Cited by
Sorted by citations
Chatterjee, S., Khunti, K., & Davies, M. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30058-2 · Cited by 2,577
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095
Lean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 1,017
“The observation of changes in liver and pancreas fat which accompany weight loss with biochemical improvements in type 2 diabetes are consistent with this.(29,8) It appears that failure to tackle that underlying process of fat accumulation allows diabetes to progress.”
BackgroundDietary and nutritional approaches for prevention and management of type 2 diabetes
Forouhi, N. G., Misra, A., Mohan, V., Taylor, R., & Yancy, W. S. (2018) · BMJ · doi:10.1136/bmj.k2234 · Cited by 513
Taylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Aribisala, B. S., Hollingsworth, K. G., Mathers, J. C., Sattar, N., & Lean, M. E. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.003 · Cited by 450
Metadata
- Authors
- Steven, S., Hollingsworth, K. G., Al-Mrabeh, A., Avery, L., Aribisala, B., Caslake, M., & Taylor, R.
- Affiliations
- Newcastle University (GB)
- Lagos State University (NG)
- University of Glasgow (GB)
- Corresponding author
- Taylor, Roy
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-03-21
- Volume
- 39
- Issue
- 5
- Pages
- 808-815
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2309974746
- Cited by
- 418
- References
- 41
- Citations by year
- 2026: 20 · 2025: 29 · 2024: 37 · 2023: 35 · 2022: 47 · 2021: 51 · 2020: 47 · 2019: 53 · 2018: 36 · 2017: 43 · 2016: 18
- FWCI
- 50.26
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-06-01)
- Open access
- green
- research.tees.ac.uk
- Licence
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Teesside University Research Portal (Teesside University) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc-nd)
- Funders
- National Institute of Health Research Newcastle Biomedical Research Center Grant
- Novo Nordisk UK Research Foundation Research Fellowship
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- type 2 diabetes, very low calorie diet, weight loss, weight maintenance, diabetes remission, fasting blood glucose, insulin sensitivity, first-phase insulin response, insulin secretion, hepatic fat content, pancreatic fat content, diabetes duration, HbA1c
- MeSH terms
- Body Weight Maintenance, Adult, Blood Glucose, Body Weight, Diabetes Mellitus, Type 2, Diet, Reducing, Fasting, Female, Humans, Insulin, Longitudinal Studies, Male, Middle Aged, Treatment Outcome, Caloric Restriction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review